Investiture of next generation probiotics on amelioration of diseases – Strains do matter

Azad, 2018, Probiotic species in the modulation of gut microbiota: an overview, BioMed Res Int, 2018, 9478630, 10.1155/2018/9478630 Chang, 2019, Next generation probiotics in disease amelioration, J Food Drug Anal, 27, 615, 10.1016/j.jfda.2018.12.011 Tsai, 2019, Probiotics, prebiotics and amelioration of diseases, J Biomed Sci, 26, 3, 10.1186/s12929-018-0493-6 Hiippala, 2018, The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation, Nutrients, 10, 10.3390/nu10080988 Wan, 2016, Modulation of intestinal epithelial defense responses by probiotic bacteria, Crit Rev Food Sci Nutr, 56, 2628, 10.1080/10408398.2014.905450 Yousefi, 2019, Probiotics importance and their immunomodulatory properties, J Cell Physiol, 234, 8008, 10.1002/jcp.27559 Molska, 2019, Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer, Nutrients, 11, 10.3390/nu11102453 Kim, 2019, Fecal microbiota transplantation: an update on clinical practice, Clin. Endosc., 52, 137, 10.5946/ce.2019.009 Wilson, 2019, The super-donor phenomenon in fecal microbiota transplantation, Front Cell Infect. Microbiol., 9, 2, 10.3389/fcimb.2019.00002 DeFilipp, 2019, Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant, N Engl J Med, 10.1056/NEJMoa1910437 O'Toole, 2017, Next-generation probiotics: the spectrum from probiotics to live biotherapeutics, Nat. Microbiol., 2, 17057, 10.1038/nmicrobiol.2017.57 Almeida, 2019, Evolving trends in next-generation probiotics: a 5W1H perspective, Crit Rev Food Sci Nutr, 1 Koutnikova, 2019, Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials, BMJ Open, 9, 10.1136/bmjopen-2017-017995 Singer, 2019, Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis, Nat Med, 25, 1772, 10.1038/s41591-019-0640-y Petrof, 2012, Probiotics in the critically ill: a systematic review of the randomized trial evidence, Crit Care Med, 40, 3290, 10.1097/CCM.0b013e318260cc33 Manzanares, 2016, Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis, Crit Care, 19, 262, 10.1186/s13054-016-1434-y Dryl, 2018, Probiotics for management of infantile colic: a systematic review of randomized controlled trials, Arch Med Sci, 14, 1137, 10.5114/aoms.2017.66055 Szymanski, 2019, Lack of efficacy of Lactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis: a randomized controlled trial, Pediatr Infect Dis J, 38, e237, 10.1097/INF.0000000000002355 Freedman, 2018, Multicenter trial of a combination probiotic for children with gastroenteritis, N Engl J Med, 379, 2015, 10.1056/NEJMoa1802597 Schnadower, 2018, Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children, N Engl J Med, 379, 2002, 10.1056/NEJMoa1802598 Zmora, 2018, Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features, Cell, 174, 1388, 10.1016/j.cell.2018.08.041 Suez, 2018, Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT, Cell, 174, 1406, 10.1016/j.cell.2018.08.047 Yelin, 2019, Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients, Nat Med, 25, 1728, 10.1038/s41591-019-0626-9 Underwood, 2019, Should we treat every infant with a probiotic?, Minerva Pediatr, 71, 253, 10.23736/S0026-4946.19.05526-9 Abid, 2019 Kaklamanos, 2019, BMJ Open, 9, 10.1136/bmjopen-2019-030638 Tiderencel, 2019, Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials, Diab. Metab. Res. Rev. Langella, 2019, Editorial: next-generation probiotics: from commensal bacteria to novel drugs and food supplements, Front Microbiol, 10, 1973, 10.3389/fmicb.2019.01973 Schwartz, 2019, Complex interactions between the microbiome and cancer immune therapy, Crit Rev Clin Lab Sci, 56, 567, 10.1080/10408363.2019.1660303 Tan, 2019, Preliminary safety assessment of a new Bacteroides fragilis isolate, Food Chem Toxicol, 110934 Saarela, 2019, Safety aspects of next generation probiotics, Curr. Opin. Food Sci., 30, 8, 10.1016/j.cofs.2018.09.001 Graspeuntner, 2019, Gut dysbiosis with bacilli dominance and accumulation of fermentation products precedes late-onset sepsis in preterm infants, Clin Infect Dis, 69, 268, 10.1093/cid/ciy882 Chua, 2019, Bacterial survival and adhesion for formulating new oral probiotic foods, Crit Rev Food Sci Nutr, 1 Barcena, 2019, Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice, Nat Med, 25, 1234, 10.1038/s41591-019-0504-5 Ansaldo, 2019, Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis, Science, 364, 1179, 10.1126/science.aaw7479 Blacher, 2019, Potential roles of gut microbiome and metabolites in modulating ALS in mice, Nature, 572, 474, 10.1038/s41586-019-1443-5 Plovier, 2017, A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat Med, 23, 107, 10.1038/nm.4236 Zhai, 2019, A next generation probiotic, Akkermansia muciniphila, Crit Rev Food Sci Nutr, 59, 3227, 10.1080/10408398.2018.1517725 Dubourg, 2017, First isolation of Akkermansia muciniphila in a blood-culture sample, Clin Microbiol Infect, 23, 682, 10.1016/j.cmi.2017.02.031 Sun, 2019, A potential species of next-generation probiotics? The dark and light sides of Bacteroides fragilis in health, Food Res Int, 126, 108590, 10.1016/j.foodres.2019.108590 Sears, 2014, Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis, J Clin Investig, 124, 4166, 10.1172/JCI72334 Wang, 2014, An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling, Nat Commun, 5, 4432, 10.1038/ncomms5432 Ramakrishna, 2019, Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis, Nat Commun, 10, 2153, 10.1038/s41467-019-09884-6 Tan, 2019, Investigations of Bacteroides spp. towards next-generation probiotics, Food Res Int, 116, 637, 10.1016/j.foodres.2018.08.088 Pathak, 2014, Bifidobacterium--friend or foe? A case of urinary tract infection with Bifidobacterium species, BMJ Case Rep, 10.1136/bcr-2014-205122 Goodrich, 2014, Human genetics shape the gut microbiome, Cell, 159, 789, 10.1016/j.cell.2014.09.053 Goodrich, 2016, Genetic determinants of the gut microbiome in UK twins, Cell Host Microbe, 19, 731, 10.1016/j.chom.2016.04.017 Yang, 2018, Effects of Christensenella minuta lipopolysaccharide on RAW 264.7 macrophages activation, Microb Pathog, 125, 411, 10.1016/j.micpath.2018.10.005 Dash, 2016, Metabolic modeling of clostridia: current developments and applications, FEMS Microbiol Lett, 363, 10.1093/femsle/fnw004 Uzal, 2018, Comparative pathogenesis of enteric clostridial infections in humans and animals, Anaerobe, 53, 11, 10.1016/j.anaerobe.2018.06.002 Tian, 2019, Effects of probiotics on chemotherapy in patients with lung cancer, Oncol. Lett., 17, 2836 Cassir, 2016, Clostridium butyricum: from beneficial to a new emerging pathogen, Clin Microbiol Infect, 22, 37, 10.1016/j.cmi.2015.10.014 Hosny, 2019, Multidisciplinary evaluation of Clostridium butyricum clonality isolated from preterm neonates with necrotizing enterocolitis in South France between 2009 and 2017, Sci Rep, 9, 2077, 10.1038/s41598-019-38773-7 Selma, 2017, Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin A from ellagic acid, Front Microbiol, 8, 1521, 10.3389/fmicb.2017.01521 Sassoubre, 2014, Enterococci as indicators of environmental fecal contamination, Enterococci: Commen Lead Caus Drug Resist Infect Daillere, 2016, Enterococcus hirae and barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects, Immunity, 45, 931, 10.1016/j.immuni.2016.09.009 Nawaz, 2019, Genomic and functional characterization of Enterococcus mundtii QAUEM2808, isolated from artisanal fermented milk product dahi, Front Microbiol, 10, 434, 10.3389/fmicb.2019.00434 Grau, 2017, Probiotic Enterococcus mundtii isolate protects the model insect Tribolium castaneum against Bacillus thuringiensis, Front Microbiol, 8, 1261, 10.3389/fmicb.2017.01261 Van Tyne, 2019, Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream, Sci Transl Med, 11, 10.1126/scitranslmed.aat8418 Tendolkar, 2003, Pathogenic enterococci: new developments in the 21st century, Cell Mol Life Sci, 60, 2622, 10.1007/s00018-003-3138-0 Duncan, 2002, Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov, Int J Syst Evol Microbiol, 52, 2141 Wrzosek, 2013, Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent, BMC Biol, 11, 61, 10.1186/1741-7007-11-61 Sedwick, 2014, A novel regulatory T cell population in the gut, PLoS Biol, 12, 10.1371/journal.pbio.1001834 Chaput, 2017, Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab, Ann Oncol, 28, 1368, 10.1093/annonc/mdx108 Sokol, 2014, Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii, Inflamm Bowel Dis, 20, E18, 10.1097/MIB.0000000000000071 Costa, 2019, Pathogenomics of emerging Campylobacter species, Clin Microbiol Rev, 32, 10.1128/CMR.00072-18 Chang, 2015, Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota, Nat Commun, 6, 7489, 10.1038/ncomms8489 Wu, 2019, Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis, Gut, 68, 248, 10.1136/gutjnl-2017-315458 Awadel-Kariem, 2010, First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection, Anaerobe, 16, 223, 10.1016/j.anaerobe.2010.01.001 Syakila, 2019, In vitro assessment of pediococci- and lactobacilli-induced cholesterol-lowering effect using digitally enhanced high-performance thin-layer chromatography and confocal microscopy, Anal Bioanal Chem, 411, 1181, 10.1007/s00216-018-1544-2 Atkins, 1994, Pediococcus pentosaceus catheter-associated infection in an infant with gastroschisis, Pediatr Infect Dis J, 13, 75, 10.1097/00006454-199401000-00018 De Vadder, 2016, Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis, Cell Metabol, 24, 151, 10.1016/j.cmet.2016.06.013 Pedersen, 2016, Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, 535, 376, 10.1038/nature18646 Jans, 2018, The road to infection: host-microbe interactions defining the pathogenicity of Streptococcus bovis/Streptococcus equinus complex members, Front Microbiol, 9, 603, 10.3389/fmicb.2018.00603 Vitetta, 2019, Gut dysbiosis and the intestinal microbiome: Streptococcus thermophilus a key probiotic for reducing uremia, Microorganisms, 7, 10.3390/microorganisms7080228 Wilcox, 2019, Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review, Clin Microbiol Infect, 25, 673, 10.1016/j.cmi.2018.12.031 Koretz, 2018, Probiotics in Gastroenterology: how pro is the evidence in adults?, Am J Gastroenterol, 113, 1125, 10.1038/s41395-018-0138-0 LeBlanc, 2013, Bacteria as vitamin suppliers to their host: a gut microbiota perspective, Curr Opin Biotechnol, 24, 160, 10.1016/j.copbio.2012.08.005 Tang, 2019, Health promoting activities of probiotics, J Food Biochem, 43 Martin, 2019, Emerging health concepts in the probiotics field: streamlining the definitions, Front Microbiol, 10, 1047, 10.3389/fmicb.2019.01047